Detalhe da pesquisa
1.
Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema.
Clin Exp Allergy
; 48(10): 1325-1332, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29998524
2.
Exposure-Response Model of Subcutaneous C1-Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary Angioedema.
CPT Pharmacometrics Syst Pharmacol
; 7(3): 158-165, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29316335
3.
Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine.
Neuropsychopharmacology
; 30(12): 2269-74, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16052246
4.
Pharmacokinetic profile of a new form of sumatriptan tablets in healthy volunteers.
Curr Med Res Opin
; 20(6): 803-9, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15200736
5.
Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency.
Biol Ther
; 4(1-2): 41-55, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25118975
6.
Pharmacodynamic consequences of administration of VLA-4 antagonist CDP323 to multiple sclerosis subjects: a randomized, double-blind phase 1/2 study.
PLoS One
; 8(3): e58438, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23472197
7.
Pharmacokinetic modeling and simulation of biweekly subcutaneous immunoglobulin dosing in primary immunodeficiency.
Postgrad Med
; 125(6): 53-61, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24200761
8.
The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects.
Br J Clin Pharmacol
; 61(2): 191-9, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16433873
9.
Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects.
Br J Clin Pharmacol
; 61(4): 420-6, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16542203